Resources
Filariasis Test Strip Quality and Reporting
The US Center for Disease Control and Prevention's Caitlin Worrell discussed filariasis test strip quality as a diagnostic tool and reporting issues with the tool on January 14, 2020.
Excerpts from Community-based health care, including outreach and campaigns, in the context of the COVID-19 pandemic
Interim guidance May 2020
Published by the World Health Organization and the United Nations Children’s Fund (UNICEF)
Mali FY2020 Work Plan
The FY2020 work plan outlines the activities that are expected to be undertaken in Mali in the next fiscal year through USAID's Act to End NTDs | West program (Act | West), managed by FHI 360 and implemented in Mali by Helen Keller International (HKI).
Act | West partners in Mali are HKI as lead implementer with technical assistance from FHI 360 and World Vision. The work plan specifies Act | West partner responsibilities for program activities in FY2020 in Mali.
Diagnostic Test Guidance
Tara Brandt of the US Centers for Disease Control and Prevention provided guidance on using diagnostic tests—particularly filariasis test strips—for diagnosing LF on January 14, 2020.
WHO Guidance for Transmission Assessment Surveys for Lymphatic Filariasis
Dr. Didier Bakajika of the World Health Organization's Global Programme to Eliminate Lymphatic Filariasis presented WHO's guidance for transmission assessment surveys at the USAID lymphatic filariasis transmission assessment survey workshop, hosted by the Act to End NTDs | West and Act to End NTDs | East programs in Abidjan, Cote d'Ivoire on January 15, 2020.
Orientations de l’OMS sur le pre-TAS
Le Dr Didier Bakajika du Programme mondial d'élimination de la filariose lymphatique de l'Organisation mondiale de la santé a présenté les orientations de l’OMS sur le pre-TAS lors de l'atelier de l'USAID sur les enquêtes d'évaluation de la transmission de la filariose lymphatique, organisé par les programmes Act to End NTDs | West et Act to End NTDs | East à Abidjan, Côte d'Ivoire, le 14 janvier 2020.
WHO Guidance for Pre-TAS
Dr. Didier Bakajika of the World Health Organization's Global Programme to Eliminate Lymphatic Filariasis presented WHO's guidance for pre-transmission assessment surveys at the USAID lymphatic filariasis transmission assessment survey workshop, hosted by the Act to End NTDs | West and Act to End NTDs | East programs in Abidjan, Cote d'Ivoire on January 14, 2020.
Implication communautaire dans la mise en oeuvre d’une enquête
Le Dr Ernest Mensah de FHI 360 a fait une présentation sur l'implication communautaire dans la mise en œuvre de l'enquête lors de l'atelier de l'USAID sur l'évaluation de la transmission de la filariose lymphatique, organisé par les programmes Act to End NTDs | West et Act to End NTDs | East à Abidjan, Côte d'Ivoire, le 15 janvier 2020.
Community Engagement in Survey Implementation
FHI 360's Dr. Ernest Mensah delivered a presentation on community engagement in survey implementation at USAID's lymphatic filariasis transmission assessment survey workshop, hosted by the Act to End NTDs | West and Act to End NTDs | East programs in Abidjan, Cote d'Ivoire on January 15, 2020.
Country Elimination Expectations‐ WHO 2030 NTD Roadmap Goals
Dr. Didier Bakajika of the World Health Organization's Global Programme to Eliminate Lymphatic Filariasis presented WHO's expectations for countries seeking validation of LF elimination and the goals of the WHO's 2030 NTD Roadmap.